196 related articles for article (PubMed ID: 23803604)
41. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling.
Bayle J; Letard S; Frank R; Dubreuil P; De Sepulveda P
J Biol Chem; 2004 Mar; 279(13):12249-59. PubMed ID: 14707129
[TBL] [Abstract][Full Text] [Related]
42. Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis.
Chu PY; Huang LY; Hsu CH; Liang CC; Guan JL; Hung TH; Shen TL
J Biol Chem; 2009 Jul; 284(30):20215-26. PubMed ID: 19473962
[TBL] [Abstract][Full Text] [Related]
43. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.
Tsujimura T; Furitsu T; Morimoto M; Isozaki K; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
Blood; 1994 May; 83(9):2619-26. PubMed ID: 7513208
[TBL] [Abstract][Full Text] [Related]
44. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
45. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor.
Hassel S; Yakymovych M; Hellman U; Rönnstrand L; Knaus P; Souchelnytskyi S
J Cell Physiol; 2006 Feb; 206(2):457-67. PubMed ID: 16155937
[TBL] [Abstract][Full Text] [Related]
46. SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation.
Rupar K; Moharram SA; Kazi JU; Rönnstrand L
Sci Rep; 2018 Apr; 8(1):6405. PubMed ID: 29686302
[TBL] [Abstract][Full Text] [Related]
47. PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.
Chen H; Bai Y; Kobayashi M; Xiao S; Barajas S; Cai W; Chen S; Miao J; Nguele Meke F; Yao C; Yang Y; Strube K; Satchivi O; Sun J; Rönnstrand L; Croop JM; Boswell HS; Jia Y; Liu H; Li LS; Altman JK; Eklund EA; Sukhanova M; Ji P; Tong W; Band H; Huang DT; Platanias LC; Zhang ZY; Liu Y
Mol Cancer Res; 2024 Jan; 22(1):94-103. PubMed ID: 37756563
[TBL] [Abstract][Full Text] [Related]
48. A change in structural integrity of c-Kit mutant D816V causes constitutive signaling.
Raghav PK; Singh AK; Gangenahalli G
Mutat Res; 2018 Mar; 808():28-38. PubMed ID: 29482074
[TBL] [Abstract][Full Text] [Related]
49. Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.
Kobayashi M; Kuroki S; Tanaka Y; Moriya Y; Kozutumi Y; Uehara Y; Ono K; Tamura K; Washizu T; Bonkobara M
Eur J Haematol; 2015 Dec; 95(6):524-31. PubMed ID: 25684098
[TBL] [Abstract][Full Text] [Related]
50. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.
Zhu MJ; Ou WB; Fletcher CD; Cohen PS; Demetri GD; Fletcher JA
Oncogene; 2007 Sep; 26(44):6386-95. PubMed ID: 17452978
[TBL] [Abstract][Full Text] [Related]
51. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
52. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.
Wollberg P; Lennartsson J; Gottfridsson E; Yoshimura A; Rönnstrand L
Biochem J; 2003 Mar; 370(Pt 3):1033-8. PubMed ID: 12444928
[TBL] [Abstract][Full Text] [Related]
53. The receptor protein tyrosine phosphatase, PTP-RO, is upregulated during megakaryocyte differentiation and Is associated with the c-Kit receptor.
Taniguchi Y; London R; Schinkmann K; Jiang S; Avraham H
Blood; 1999 Jul; 94(2):539-49. PubMed ID: 10397721
[TBL] [Abstract][Full Text] [Related]
54. Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.
Zhang X; Lavoie G; Méant A; Aubert L; Cargnello M; Haman A; Hoang T; Roux PP
Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28096188
[TBL] [Abstract][Full Text] [Related]
55. In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit.
Corbin AS; Demehri S; Griswold IJ; Wang Y; Metcalf CA; Sundaramoorthi R; Shakespeare WC; Snodgrass J; Wardwell S; Dalgarno D; Iuliucci J; Sawyer TK; Heinrich MC; Druker BJ; Deininger MW
Blood; 2005 Jul; 106(1):227-34. PubMed ID: 15746079
[TBL] [Abstract][Full Text] [Related]
56. Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling.
Kazi JU; Rönnstrand L
PLoS One; 2012; 7(12):e53509. PubMed ID: 23300935
[TBL] [Abstract][Full Text] [Related]
57. A shift of dynamic equilibrium between the KIT active and inactive states causes drug resistance.
Srikakulam SK; Bastys T; Kalinina OV
Proteins; 2020 Nov; 88(11):1434-1446. PubMed ID: 32530065
[TBL] [Abstract][Full Text] [Related]
58. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.
Frost MJ; Ferrao PT; Hughes TP; Ashman LK
Mol Cancer Ther; 2002 Oct; 1(12):1115-24. PubMed ID: 12481435
[TBL] [Abstract][Full Text] [Related]
59. Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region.
Chan PM; Ilangumaran S; La Rose J; Chakrabartty A; Rottapel R
Mol Cell Biol; 2003 May; 23(9):3067-78. PubMed ID: 12697809
[TBL] [Abstract][Full Text] [Related]
60. I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development.
Orinska Z; Föger N; Huber M; Marschall J; Mirghomizadeh F; Du X; Scheller M; Rosenstiel P; Goldmann T; Bollinger A; Beutler BA; Bulfone-Paus S
Blood; 2010 Oct; 116(15):2665-75. PubMed ID: 20595514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
